MET and renal cell carcinoma: Here we report c-MET expression on CD105+ CD24− RCC stem cells which, implanted SC in NOD-SCID mice, recreate the heterogeneity of the primary tumor, including a subpopulation of RCC stem cells expressing CD105 and c-MET.